Zhejiang Jolly Pharmaceutical Co.,LTD reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 495.7 million compared to CNY 439.42 million a year ago. Revenue was CNY 495.7 million compared to CNY 439.42 million a year ago.

Net income was CNY 97.45 million compared to CNY 68.75 million a year ago. Basic earnings per share from continuing operations was CNY 0.1389 compared to CNY 0.113 a year ago. Diluted earnings per share from continuing operations was CNY 0.1389 compared to CNY 0.113 a year ago.